PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-06-12

Date Title Company
12-Jun-2025 Tenon Medical Announces Initial Case Series Utilizing Catamaran(R) SI Joint Fusion System to Enhance Stabilization of the SI Joint for Patients Undergoing Lumbar Fusion ACCESS Newswire
12-Jun-2025 Oxeltis and Molecular Forecaster forge strategic collaboration to enhance client’s drug design and synthesis Andrew Lloyd Associates
12-Jun-2025 Best Hybrid THC Vape Pens 2025: Area 52 Voted #1 for Balanced Hybrid Carts, Vapes, Pens & Disposables ACCESS Newswire
12-Jun-2025 AlzeCure receives positive FDA response regarding Phase II/III studies with ACD440 in a rare disease ACCESS Newswire
12-Jun-2025 Centrifugal Blood Pump Market to Reach USD 191.9 Million by 2035, Growing at 3.6% CAGR from USD 134.7 Million in 2025 MARKITWIRED
12-Jun-2025 Autoclave Market on the Rise USD 3.68 Billion Forecast by 2034 with Consistent 4.70% CAGR Growth MARKITWIRED
12-Jun-2025 Fiducial Markers Market to USD 430.2 Million by 2035 at 8.7% CAGR MARKITWIRED
12-Jun-2025 Rapid Infuser Market to Hit $348.1M by 2035 4.6% CAGR MARKITWIRED
12-Jun-2025 MPH Health Care AG publishes figures for the first quarter of 2025: MPH Health Care AG
12-Jun-2025 Laryngoscopes Market Trends and Forecast Analysis, 2025 Through 2035 MARKITWIRED
12-Jun-2025 Intrauterine Insemination Devices Market Report 2025 to 2035, Size Estimation, Demand Trends, and Future Outlook MARKITWIRED
12-Jun-2025 Poultry Diagnostics Market Demand Forecast and Growth Outlook 2025 to 2035 MARKITWIRED
12-Jun-2025 Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Insights, Demand, and Forecast to 2035 MARKITWIRED
12-Jun-2025 Relief Therapeutics Announces Results of Annual General Meeting ACCESS Newswire
12-Jun-2025 As Federal Protections for State Medical Marijuana Collapse - MMJ International Holdings Stands Alone on Legal Ground ACCESS Newswire
12-Jun-2025 BioInvent Presents Promising Phase 2a Monotherapy Data for BI-1808 in CTCL at EHA 2025 ACCESS Newswire
12-Jun-2025 Faron Pharmaceuticals presents updated Phase II data from BEXMAB Study at EHA 2025 ACCESS Newswire